Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Beeson

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
Biorxiv : the Preprint Server for Biology|February 26, 2024
Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myastheniaJudith Cossins, Imre Kozma, Claudia Canzonetta, et al.
Brain : a Journal of Neurology|March 3, 2012
A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductanceRichard Webster, Susan Maxwell, Hayley Spearman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 16, 2002
Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigenIan Matthews, Gary Sims, Serena Ledwidge, et al.
Orphanet Journal of Rare Diseases|November 28, 2018
A nomenclature and classification for the congenital myasthenic syndromes: preparing for FAIR data in the genomic eraRachel Thompson, Angela Abicht, David Beeson, et al.
Brain Communications|February 13, 2025
Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myastheniaJudith Cossins, Imre Kozma, Claudia Canzonetta, et al.
Muscle & Nerve|January 3, 2013
Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamolSarah Finlayson, Jennifer Spillane, Dimitri M Kullmann, et al.
Annals of the New York Academy of Sciences|December 21, 2012
Antibodies identified by cell-based assays in myasthenia gravis and associated diseasesAngela Vincent, Patrick Waters, M Isabel Leite, et al.
Neurology|August 23, 2015
Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromesPedro M Rodríguez Cruz, Jacqueline Palace, Hayley Ramjattan, et al.
Annals of the New York Academy of Sciences|January 3, 2013
Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndromeKatsiaryna Belaya, Sarah Finlayson, Judith Cossins, et al.
Annals of the New York Academy of Sciences|January 25, 2018
Myasthenic syndromes due to defects in COL13A1 and in the N-linked glycosylation pathwayDavid Beeson, Judith Cossins, Pedro M Rodriguez Cruz, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Biorxiv : the Preprint Server for Biology|February 26, 2024
Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myastheniaJudith Cossins, Imre Kozma, Claudia Canzonetta, et al.
Brain : a Journal of Neurology|March 3, 2012
A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductanceRichard Webster, Susan Maxwell, Hayley Spearman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 16, 2002
Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigenIan Matthews, Gary Sims, Serena Ledwidge, et al.
Orphanet Journal of Rare Diseases|November 28, 2018
A nomenclature and classification for the congenital myasthenic syndromes: preparing for FAIR data in the genomic eraRachel Thompson, Angela Abicht, David Beeson, et al.
Brain Communications|February 13, 2025
Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myastheniaJudith Cossins, Imre Kozma, Claudia Canzonetta, et al.
Muscle & Nerve|January 3, 2013
Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamolSarah Finlayson, Jennifer Spillane, Dimitri M Kullmann, et al.
Annals of the New York Academy of Sciences|December 21, 2012
Antibodies identified by cell-based assays in myasthenia gravis and associated diseasesAngela Vincent, Patrick Waters, M Isabel Leite, et al.
Neurology|August 23, 2015
Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromesPedro M Rodríguez Cruz, Jacqueline Palace, Hayley Ramjattan, et al.
Annals of the New York Academy of Sciences|January 3, 2013
Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndromeKatsiaryna Belaya, Sarah Finlayson, Judith Cossins, et al.
Annals of the New York Academy of Sciences|January 25, 2018
Myasthenic syndromes due to defects in COL13A1 and in the N-linked glycosylation pathwayDavid Beeson, Judith Cossins, Pedro M Rodriguez Cruz, et al.
Pageof 14